Dr. Mille is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
925 Chestnut St
Ste 320A
Philadelphia, PA 19107Phone+1 215-955-8874Fax+1 215-955-2340
Summary
- Dr. Patrick Mille is an oncologist in Philadelphia, PA and is affiliated with Thomas Jefferson University Hospitals. He received his medical degree from Medical University of South Carolina College of Medicine and has been in practice 7 years. He has a clinical focus on genitourinary malignancies.
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2014 - 2017
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2010 - 2013
- Medical University of South CarolinaClass of 2010
Certifications & Licensure
- DE State Medical License 2018 - 2025
- NJ State Medical License 2019 - 2025
- PA State Medical License 2010 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study Start of enrollment: 2019 Jun 07
- Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8) Start of enrollment: 2018 Oct 11
Publications & Presentations
PubMed
- 1 citationsT-Cell redirecting bispecific antibodies: a review of a novel class of immuno-oncology for advanced prostate cancer.Julia Palecki, Amman Bhasin, Andrew Bernstein, Patrick J Mille, William J Tester
Cancer Biology & Therapy. 2024-12-31 - 11 citationsPretest Genetic Education Video Versus Genetic Counseling for Men Considering Prostate Cancer Germline Testing: A Patient-Choice Study to Address Urgent Practice Needs.Jessica Russo, Carey McDougall, Nicholas Bowler, Ayako Shimada, Laura Gross
JCO Precision Oncology. 2021-09-01 - 13 citationsComplement inhibition with eculizumab for thrombotic microangiopathy rescues a living-donor kidney transplant in a patient with antiphospholipid antibody syndromePraveen Ramakrishnan Geethakumari, Patrick Mille, Rakesh Gulati, Srikanth Nagalla
Transfusion and Apheresis Science. 2017-06-01
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: